Journal Mobile Options
Table of Contents
Vol. 105, No. 2-4, 2004
Issue release date: 2004

New mouse genetic models for human contraceptive development

Lessard C. · Pendola J.K. · Hartford S.A. · Schimenti J.C. · Handel M.A. · Eppig J.J.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Genetic strategies for the post-genomic sequence age will be designed to provide information about gene function in a myriad of physiological processes. Here an ENU mutagenesis program (http://reprogenomics.jax.org) is described that is generating a large resource of mutant mouse models of infertility; male and female mutants with defects in a wide range of reproductive processes are being recovered. Identification of the genes responsible for these defects, and the pathways in which these genes function, will advance the fields of reproduction research and medicine. Importantly, this program has potential to reveal novel human contraceptive targets.   



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Aitken RJ: Immunocontraceptive vaccines for human use. J Reprod Immunol 57:273–287 (2002).
  2. Anderson RA, Baird DT: Male contraception. Endocr Rev 23:735–762 (2002).
  3. Avidan N, Tamary H, Dgany O, Cattan D, Pariente A, Thulliez M, Borot N, Moati L, Barthelme A, Shalmon L, Krasnov T, Ben-Asher E, Olender T, Khen M, Yaniv I, Zaizov R, Shalev H, Delaunay J, Fellous M, Lancet D, Beckmann JS: CATSPER2, a human autosomal nonsyndromic male infertility gene. Eur J Hum Genet 11:497–502 (2003).
  4. Balling R: ENU mutagenesis: analyzing gene function in mice. A Rev Genomics Hum Genet 2:463–492 (2001).
  5. Botstein D, Risch N: Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genet 33(suppl):228–237 (2003).
  6. Brewis IA, Wong CH: Gamete recognition: sperm proteins that interact with the egg zona pellucida. Rev Reprod 4:135–142 (1999).
  7. Cho C, Bunch DO, Faure JE, Goulding EH, Eddy EM, Primakoff P, Myles DG: Fertilization defects in sperm from mice lacking fertilin beta. Science 281:1857–1859 (1998).
  8. Cooke HJ, Saunders PT: Mouse models of male infertility. Nature Rev Genet 3:790–801 (2002).
  9. Delves PJ, Lund T, Roitt IM: Antifertility vaccines. Trends Immunol 23:213–219 (2002).
  10. Eddy EM, Washburn TF, Bunch DO, Goulding EH, Gladen BC, Lubahn DB, Korach KS: Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 137:4796–4805 (1996).
  11. Eppig JJ, O’Brien MJ: Development in vitro of mouse oocytes from primordial follicles. Biol Reprod 54:197–207 (1996).
  12. Fisher CR, Graves KH, Parlow AF, Simpson ER: Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci USA 95:6965–6970 (1998).
  13. Hess RA, Bunick D, Lee KH, Bahr J, Taylor JA, Korach KS, Lubahn DB: A role for oestrogens in the male reproductive system. Nature 390:509–512 (1997).
  14. Ho Y, Wigglesworth K, Eppig JJ, Schultz RM: Preimplantation development of mouse embryos in KSOM: Augmentation by amino acids and analysis of gene expression. Mol Reprod Dev 41:232–238 (1995).
  15. Justice MJ: Mutagenesis of the mouse germline, in Jackson JJ, Abbott CM (eds): Mouse Genetics and Transgenics: A Practical Approach, (Oxford University Press, Oxford 1999).
  16. Lincoln JA, Wickramasinghe D, Stein P, Schultz RM, Palko ME, De Miguel MP, Tessarollo L, Donavan PJ: Cdc25b phosphatase is required for resumption of meiosis during oocyte maturation. Nature Genetics 30:446–449 (2002).
  17. Matzuk MM, Lamb DJ: Genetic dissection of mammalian fertility pathways. Nature Cell Biol 4 (suppl): s41–s49 (2002).
  18. McLeskey SB, Dowds C, Carballada R, White RR, Saling PM: Molecules involved in mammalian sperm-egg interaction. Int Rev Cytol 177:57–113 (1998).
  19. Noveroske JK, Weber JS, Justice MJ: The mutagenic action of N-ethyl-N-nitrosourea in the mouse. Mammal Genome 11:478–483 (2000).
  20. O’Brien MJ, Pendola JK, Eppig JJ: A revised protocol for in vitro development of mouse oocytes from primordial follicles dramatically improves their developmental competence. Biol Reprod 68:1682–1686 (2003).
  21. Quill TA, Ren D, Clapham DE, Garbers DL: A voltage-gated ion channel expressed specifically in spermatozoa. Proc Natl Acad Sci USA 98:12527–12531 (2001).
  22. Ren D, Navarro B, Perez G, Jackson AC, Hsu S, Shi Q, Tilly JL, Clapham DE: A sperm ion channel required for sperm motility and male fertility. Nature 413:603–609 (2001).
  23. Robertson KM, O’Donnell L, Jones ME, Meachem SJ, Boon WC, Fisher CR, Graves KH, McLachlan RI, Simpson ER: Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proc Natl Acad Sci USA 96:7986–7991 (1999).
  24. Schultz N, Hamra FK, Garbers DL: A multitude of genes expressed solely in meiotic or postmeiotic spermatogenic cells offers a myriad of contraceptive targets. Proc Natl Acad Sci USA 100:12201–12206 (2003).
  25. Shah K, Sivapalan G, Gibbons N, Tempest H, Griffin DK: The genetic basis of infertility. Reproduction 126:13–25 (2003).
  26. Shibuya T, Morimoto K: A review of the genotoxicity of 1-ethyl-1-nitrosourea. Mutat Res 297:3–38 (1993).
  27. Spehr M, Gisselmann G, Poplawski A, Riffell JA, Wetzel CH, Zimmer RK, Hatt H: Identification of a testicular odorant receptor mediating human sperm chemotaxis. Science 299:2054–2058 (2003).
  28. Suarez SS: Carbohydrate-mediated formation of the oviductal sperm reservoir in mammals. Cells Tissues Organs 168:105–112 (2001).
  29. Suarez SS: Formation of a reservoir of sperm in the oviduct. Reprod Domest Anim 37:140–143 (2002).
  30. Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, Bondy CA, Dean J, Nelson LM: Mater, a maternal effect gene required for early embryonic development in mice. Nat Genet 26:267–268 (2000).
  31. Tung KS, Teuscher C: Mechanisms of autoimmune disease in the testis and ovary. Hum Reprod Update 1:35–50 (1995).
  32. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG et al: The sequence of the human genome. Science 291:1304–1351 (2001).
  33. Venter JC, Levy S, Stockwell T, Remington K, Halpern A: Massive parallelism, randomness and genomic advances. Nature Genet 33(suppl):219–227 (2003).
  34. Waites GM: Development of methods of male contraception: impact of the World Health Organization Task Force. Fertil Steril 80:1–15 (2003).
  35. Ward JO, Reinholdt LG, Hartford SA, Wilson LA, Munroe RJ, Schimenti KJ, Libby BJ, O’Brien M, Pendola JK, Eppig J, Schimenti JC: Towards the genetics of mammalian reproduction: induction and mapping of gametogenesis mutants in mice. Biol Reprod 69:1615–1625 (2003).
  36. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF et al: Initial sequencing and comparative analysis of the mouse genome. Nature 420:520–562 (2002).
  37. Yanagimachi R: Mammalian fertilization, in Knobil E, Neill J (eds): The Physiology of Reproduction, pp 189–317, 2nd ed (Raven Press, New York 1994).


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50